Latest News » All Healthcare News » Launch of Biotechnology Portal cellexis.com - Marketing of Innovative Cell Culture Technology
Launch of Biotechnology Portal cellexis.com - Marketing of Innovative Cell Culture Technology
atech system solutions Ltd. ("atech") has launched the online service www.cellexis.com for marketing and distribution of innovative products and services in the field of cell culture technology.
WIESBADEN, GERMANY, September 21, 2011 /24-7PressRelease/ -- With the online service www.cellexis.com, atech system solutions Ltd., based in London, UK, and Wiesbaden, Germany, has established its most important global distribution channel for the independently developed technology, i.e. the bioreactor platform cellexis one and the modular process technology. atech consistently commits itself to direct distribution and sales of equipment and know-how without entering into distribution partnerships. The online service www.cellexis.com is the portal for distribution of bioreactor systems that are marketed under the name "cellexis one" and services like the delivery of manufacturing processes for cell culture products according to international standards.
"Processes in the field of cell culture technology, primarily using mammalian cells, are usually very complex and difficult to standardize," explains Dr. Soheil Asgari, atech's Chief Technology Officer. "With the cellexis technology, i.e. our particular bioreactors, an unprecedented standardization of production processes are feasible. Since our systems are very close to the „plug and play" principle, we have intentionally opted for direct sales. "atech sees particularly in direct sales a significant competitive advantage because the lower transaction costs will be passed directly on to customers.
Bioreactors comprising cellexis technology per se reduce the need for investment in production technology, since they are associated with significantly lower hardware and infrastructure costs. In addition, the savings of direct operating costs are in the range by up to 70% over conventional production methods. "In order to use the cellexis technology, the use of so-called semi-adherent or adherent cell lines is required, i.e. such cell cultures, which grow adhering to surfaces. With the online service www.cellexis.com we provide not only the available hardware, but also the know-how for the implementation, process development and industrial-scale production," adds Dr. Soheil Asgari.
Through the online service www.cellexis.com, atech handles hardware sales of bioreactor systems and disposable bioreactor vessels, spare part supplies and technical support including consulting services for process development. In addition, the licensing of the cellexis technology will be supported and handled electronically through the online portal on the basis of standard licensing agreements. atech considers the standardization of licensing agreements as a key to further reduce significantly transaction costs, but in particular life cycle costs and time to market. Further information is available at http://www.cellexis.com.
Press Release Contact Information:
Sohéil Dr. Asgari
atech System Solutions Ltd.
Chief Technology Officer
Mainzer Str. 10
Wiesbaden, HE
Germany 65185
Voice: +49 611 172 77 55 30
Website: Visit Our Website


